For research use only. Not for therapeutic Use.
WYC-210, a Tazarotene derivative, is a retinoid compound with lower anticancer activity[1].<br>WYC-210 (10 μM; 5 days) inhibits cell growth of B16-F1 TRC cells with an inhibition rate of 18.1%[1].
| Catalog Number | I014908 |
| CAS Number | 2131803-93-3 |
| Molecular Formula | C₁₈H₁₆N₂O₃S |
| Purity | ≥95% |
| Reference | [1]. Cao, Xin, et al. Preparation of the retinoid compound and their application as anticancer agents. WO2017152725A1. |
